Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-29

FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Alprazolam by Sandoz Inc, a generic benzodiazepine used to treat anxiety disorders such as generalized anxiety d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (generic) (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)